Fujian Wanchen Biotechnology Co. Ltd (300972) — Financial Flexibility Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Financial Flexibility Index of 0.49x as of December 2025. Free cash flow of CN¥3.71 Billion (operating CF CN¥3.63 Billion minus capex CN¥77.44 Million) represents 0% of total liabilities (CN¥7.50 Billion). Check Fujian Wanchen Biotechnology Co. Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fujian Wanchen Biotechnology Co. Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Fujian Wanchen Biotechnology Co. Ltd.
Annual Financial Flexibility Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Fujian Wanchen Biotechnology Co. Ltd. Explore 300972 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥3.71 Billion | CN¥3.63 Billion | CN¥7.50 Billion | ▲ +197.0% |
| 2024 | 0.17x | CN¥965.00 Million | CN¥848.35 Million | CN¥5.79 Billion | ▼ -56.7% |
| 2023 | 0.38x | CN¥1.24 Billion | CN¥1.02 Billion | CN¥3.23 Billion | ▼ -47.4% |
| 2022 | 0.73x | CN¥386.72 Million | CN¥70.38 Million | CN¥528.79 Million | ▲ +9.6% |
| 2021 | 0.67x | CN¥140.40 Million | CN¥98.82 Million | CN¥210.47 Million | ▼ -19.0% |
| 2020 | 0.82x | CN¥212.34 Million | CN¥156.24 Million | CN¥257.94 Million | ▲ +17.9% |
| 2019 | 0.70x | CN¥217.01 Million | CN¥177.28 Million | CN¥310.81 Million | — |